Brain imaging techniques using PET improve our understanding of the different AD-related
pathologies and their relationship with each other along the course of disease. With more …

With improvements to both scan quality and facial recognition software, there is an
increased risk of participants being identified by a 3D render of their structural neuroimaging …

Background Although previously thought to be asymptomatic, recent studies have
suggested that magnetic resonance imaging–visible perivascular spaces (PVS) in the basal …

Background and Objective: Olfactory dysfunction (hyposmia) is an important non-motor
symptom of Parkinson's disease (PD). To investigate the potential prognostic value of …

The absence of disease modifying treatments for amyotrophic lateral sclerosis (ALS) is in
large part a consequence of its complexity and heterogeneity. Deep clinical and biological …

Introduction Understanding synergies between neurodegenerative and cerebrovascular
pathologies that modify dementia presentation represents an important knowledge gap …

Background and purpose The pathophysiology of Parkinson's disease (PD) negatively
affects brain network connectivity, and in the presence of brain white matter hyperintensities …

Type 2 diabetes mellitus (T2DM) and hypertension are risk factors for cerebral small vessel
disease (SVD); however, few studies have characterised their relationships with MRI-visible …

Background Cerebral small vessel disease is associated with higher ratios of soluble‐
epoxide hydrolase derived linoleic acid diols (12, 13‐dihydroxyoctadecenoic acid [DiHOME] …

Introduction Processing speed and executive function are often impaired after stroke and in
typical aging. However, there are no reliable neurological markers of these cognitive …